Genomic characterization of multidrug-resistant extended-spectrum β-lactamase-producing <i>Vibrio cholerae</i> O1 strains from 2022 cholera outbreak in Kenya
The high prevalence of multidrug resistance in cholera isolates emphasizes the need for continuous surveillance to monitor the evolution of MDR V. cholerae O1 strains and calls for consideration of deployment of alternative management and prevention options including oral cholera vaccines and long-term improvement of water, sanitation and hygiene (WASH) infrastructure and practice.
Authors
- Cecilia Mbae (ORCID: https://orcid.org/0000-0002-6933-248X)
- Celestine Wairimu
- John M. Maingi
- Samuel Kariuki (ORCID: https://orcid.org/0000-0003-3209-9503)
- Wondwossen A. Gebreyes (ORCID: https://orcid.org/0000-0003-1885-3952)
- Georgina Odityo
- Zelalem Mekuria
- Susan Kavai (ORCID: https://orcid.org/0000-0003-4617-9985)
- Diana Imoli (ORCID: https://orcid.org/0009-0000-5497-7018)
- Sheilla Mundalo
- Mary Wairimu
Institutions
- Drugs for Neglected Diseases Initiative (CH)
- Kenyatta University (KE)
- Ohio Department of Health (US)
- Wellcome Sanger Institute (GB)
- Kenya Medical Research Institute (KE)
- The Ohio State University (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1093/jac/dkaf224
- Citations
- 2
- Primary Topic
- Vibrio bacteria research studies
- Type
- article
- Field-Weighted Citation Impact
- 3.60